ID,SMILES,BBB penetration,Human PPBR,VDss (L/kg),Cell Effective Permeability (cm/s),Human Intestinal Absorption,Bioavailability,Lipophilicity log-ratio,Solubility (log mol/L),CYP P450 2D6 Inhibition,CYP P450 2C9 Inhibition,CYP P450 3A4 Inhibition,CYP2C9 Substrate,CYP3A4 Substrate,CYP2D6 Substrate,hepatocyte clearance (uL.min-1.(10^6 cells)-1),drug microsome clearance (mL.min-1.g-1),hERG blocker,LD50 (log(1/(mol/kg)))
cannabigerolic acid,CCCCCC1=CC(=C(C(=C1C(=O)O)O)C/C=C(\C)/CCC=C(C)C)O,0.0,90.24580580342119,2.295064285714282,5.4671173095703125,1.0,0.0,1.644581728333019,3.8090038299560547,0.0,0.0,0.0,0.0,1.0,0.0,57.871897125244146,8.610123920440675,1.0,2.47685999127812
cannabigerolic acid monomethylether,CCCCCC1=CC(=C(C(=C1C(=O)O)O)C/C=C(\C)/CCC=C(C)C)OC,0.0,91.34269123599925,2.914471428571425,5.3310980796813965,1.0,1.0,1.139235592951402,5.992486953735352,0.0,0.0,0.0,0.0,1.0,0.0,76.19283294677734,10.097715377807617,1.0,2.5859918592113162
cannabigerol,CCCCCC1=CC(=C(C(=C1)O)C/C=C(\C)/CCC=C(C)C)O,1.0,83.42799559861565,6.287907142857139,5.406434535980225,1.0,0.0,2.6376313573460486,5.805845737457275,0.0,0.0,0.0,0.0,1.0,0.0,124.16295471191407,10.70243730545044,1.0,2.4103482930214484
test_invalid,CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O$)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O,,,,,,,,,,,,,,,,,,
